[
  {
    "ts": null,
    "headline": "Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks",
    "summary": "Quest Diagnostics Inc. (NYSE:DGX) delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance. However, the diagnostic test provider flagged potential headwinds from ongoing tariffs and the significant financial impact if the Protecting Access to Medicare Act (PAMA) is not deferred, setting the stage for a watchful eye on legislative and trade developments. For the second quarter of 2025,",
    "url": "https://finnhub.io/api/news?id=55a1f496b22bdffe5d8381b958a10f509925f1d0e789049856ba2060a5b17b8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753204248,
      "headline": "Quest Diagnostics Raises Outlook, But Warns Of Tariff And Medicare Act Risks",
      "id": 136033924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics Inc. (NYSE:DGX) delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales and earnings growth, prompting an upward revision to its full-year guidance. However, the diagnostic test provider flagged potential headwinds from ongoing tariffs and the significant financial impact if the Protecting Access to Medicare Act (PAMA) is not deferred, setting the stage for a watchful eye on legislative and trade developments. For the second quarter of 2025,",
      "url": "https://finnhub.io/api/news?id=55a1f496b22bdffe5d8381b958a10f509925f1d0e789049856ba2060a5b17b8a"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics Inc. stock outperforms competitors on strong trading day",
    "summary": "Quest Diagnostics Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=2cf5409974f9c2a3fedf550c3c08d68bc7ade0669c504ca2823a627a0dbb3a5d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753201800,
      "headline": "Quest Diagnostics Inc. stock outperforms competitors on strong trading day",
      "id": 136059888,
      "image": "",
      "related": "DGX",
      "source": "MarketWatch",
      "summary": "Quest Diagnostics Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=2cf5409974f9c2a3fedf550c3c08d68bc7ade0669c504ca2823a627a0dbb3a5d"
    }
  },
  {
    "ts": null,
    "headline": "Why Quest (DGX) Stock Is Up Today",
    "summary": "Shares of healthcare diagnostics company Quest Diagnostics (NYSE:DGX) jumped 6.4% in the morning session after the company reported strong second-quarter financial results that beat Wall Street expectations and raised its full-year guidance.",
    "url": "https://finnhub.io/api/news?id=31ebdf7bbaaa130cb2069957de4a781da1fc1b2cdb0d701726d57ba54fcf135e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753199780,
      "headline": "Why Quest (DGX) Stock Is Up Today",
      "id": 136033925,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Shares of healthcare diagnostics company Quest Diagnostics (NYSE:DGX) jumped 6.4% in the morning session after the company reported strong second-quarter financial results that beat Wall Street expectations and raised its full-year guidance.",
      "url": "https://finnhub.io/api/news?id=31ebdf7bbaaa130cb2069957de4a781da1fc1b2cdb0d701726d57ba54fcf135e"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y",
    "summary": "DHR tops Q2 estimates with strong sales across segments, lifting its 2025 EPS outlook amid mixed margin trends.",
    "url": "https://finnhub.io/api/news?id=b293eafdfcc0898f59ca0235761eaee9ebefbd05248bccc541b4a8356b006ce5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753197300,
      "headline": "Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y",
      "id": 136033551,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "DHR tops Q2 estimates with strong sales across segments, lifting its 2025 EPS outlook amid mixed margin trends.",
      "url": "https://finnhub.io/api/news?id=b293eafdfcc0898f59ca0235761eaee9ebefbd05248bccc541b4a8356b006ce5"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises",
    "summary": "DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.",
    "url": "https://finnhub.io/api/news?id=478ddf1df6095e99f0103e03d88e11e78f7f319684045ad8ff415c43ddff68a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753187940,
      "headline": "Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises",
      "id": 136033723,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.",
      "url": "https://finnhub.io/api/news?id=478ddf1df6095e99f0103e03d88e11e78f7f319684045ad8ff415c43ddff68a4"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics Incorporated 2025 Q2 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Quest Diagnostics Incorporated in conjunction with their 2025 Q2 earnings call.",
    "url": "https://finnhub.io/api/news?id=6e9defef0800ec940294a635fedf25b5bf4144a27b663cdb61cba551ec2df9e7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753186930,
      "headline": "Quest Diagnostics Incorporated 2025 Q2 - Results - Earnings Call Presentation",
      "id": 136032756,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "DGX",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Quest Diagnostics Incorporated in conjunction with their 2025 Q2 earnings call.",
      "url": "https://finnhub.io/api/news?id=6e9defef0800ec940294a635fedf25b5bf4144a27b663cdb61cba551ec2df9e7"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript",
    "summary": "Quest Diagnostics Incorporated (NYSE:DGX) Q2 2025 Earnings Conference Call July 22, 2025 8:30 AM ETCompany ParticipantsJames E.",
    "url": "https://finnhub.io/api/news?id=9ee4a65be2a3884ad5f2c96e374394b185079a3467c3305a998f1ec43993b5de",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753186920,
      "headline": "Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript",
      "id": 136032758,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "DGX",
      "source": "SeekingAlpha",
      "summary": "Quest Diagnostics Incorporated (NYSE:DGX) Q2 2025 Earnings Conference Call July 22, 2025 8:30 AM ETCompany ParticipantsJames E.",
      "url": "https://finnhub.io/api/news?id=9ee4a65be2a3884ad5f2c96e374394b185079a3467c3305a998f1ec43993b5de"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics (DGX) Beats Q2 Earnings and Revenue Estimates",
    "summary": "Quest Diagnostics (DGX) delivered earnings and revenue surprises of +1.95% and +1.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=0db308bc63b400f315580043c803d16ef9a0ab88ecea8dd3334497d98f780424",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753185302,
      "headline": "Quest Diagnostics (DGX) Beats Q2 Earnings and Revenue Estimates",
      "id": 136032238,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics (DGX) delivered earnings and revenue surprises of +1.95% and +1.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=0db308bc63b400f315580043c803d16ef9a0ab88ecea8dd3334497d98f780424"
    }
  },
  {
    "ts": null,
    "headline": "Quest (NYSE:DGX) Surprises With Q2 Sales",
    "summary": "Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q2 CY2025, with sales up 15.2% year on year to $2.76 billion. The company’s full-year revenue guidance of $10.86 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $2.62 per share was 1.9% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=3e9fe2dadc607d4f0fa378e2e67b04a0202e60bcdb814b51b615b3d4d3a3a3b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753182347,
      "headline": "Quest (NYSE:DGX) Surprises With Q2 Sales",
      "id": 136032239,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q2 CY2025, with sales up 15.2% year on year to $2.76 billion. The company’s full-year revenue guidance of $10.86 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $2.62 per share was 1.9% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=3e9fe2dadc607d4f0fa378e2e67b04a0202e60bcdb814b51b615b3d4d3a3a3b1"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics: Q2 Earnings Snapshot",
    "summary": "SECAUCUS, N.J. (AP) — Quest Diagnostics Inc. DGX) on Tuesday reported second-quarter net income of $282 million. The Secaucus, New Jersey-based company said it had net income of $2.47 per share.",
    "url": "https://finnhub.io/api/news?id=eb22c76674a27e4a2a993d4b40322eb34e9c8926aa7c992b402ae154e8cbee19",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753181917,
      "headline": "Quest Diagnostics: Q2 Earnings Snapshot",
      "id": 136032240,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "SECAUCUS, N.J. (AP) — Quest Diagnostics Inc. DGX) on Tuesday reported second-quarter net income of $282 million. The Secaucus, New Jersey-based company said it had net income of $2.47 per share.",
      "url": "https://finnhub.io/api/news?id=eb22c76674a27e4a2a993d4b40322eb34e9c8926aa7c992b402ae154e8cbee19"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025",
    "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the second quarter ended June 30, 2025.",
    "url": "https://finnhub.io/api/news?id=af146dcdbd032a83a7d890a05457f8c1d340873527c0fe6f6d59fc3639c58930",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753181220,
      "headline": "Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025",
      "id": 136032241,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the second quarter ended June 30, 2025.",
      "url": "https://finnhub.io/api/news?id=af146dcdbd032a83a7d890a05457f8c1d340873527c0fe6f6d59fc3639c58930"
    }
  },
  {
    "ts": null,
    "headline": "Deep Sail Capital Partner Q2 2025 Investor Letter",
    "summary": "Deep Sail Capital Partner Q2 2025 Investor Letter",
    "url": "https://finnhub.io/api/news?id=bb9cb6cbf109c77df0e2a871c11ebd0f01bb6ff3168497363bb37e524d1f2dfc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753179000,
      "headline": "Deep Sail Capital Partner Q2 2025 Investor Letter",
      "id": 136032534,
      "image": "",
      "related": "DGX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=bb9cb6cbf109c77df0e2a871c11ebd0f01bb6ff3168497363bb37e524d1f2dfc"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics Ups FY Rev Guidance as 2Q Profit, Rev Rise",
    "summary": "Quest Diagnostics Ups FY Rev Guidance as 2Q Profit, Rev Rise",
    "url": "https://finnhub.io/api/news?id=1533601ae52db13a638827b3bc5cfb8c5bed84ea17f1498e1ee107d883daddaa",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753169580,
      "headline": "Quest Diagnostics Ups FY Rev Guidance as 2Q Profit, Rev Rise",
      "id": 136059889,
      "image": "",
      "related": "DGX",
      "source": "MarketWatch",
      "summary": "Quest Diagnostics Ups FY Rev Guidance as 2Q Profit, Rev Rise",
      "url": "https://finnhub.io/api/news?id=1533601ae52db13a638827b3bc5cfb8c5bed84ea17f1498e1ee107d883daddaa"
    }
  },
  {
    "ts": null,
    "headline": "Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)",
    "summary": "Fresenius Medical Care (FMS) shows strong growth, with shares up 32.95% YoY and net income up 60%.",
    "url": "https://finnhub.io/api/news?id=83b07a312a7f7754f62829c379b3db180b810a2ae520db47a46e34d9a6e63f97",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753169460,
      "headline": "Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)",
      "id": 136030627,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/458689515/image_458689515.jpg?io=getty-c-w1536",
      "related": "DGX",
      "source": "SeekingAlpha",
      "summary": "Fresenius Medical Care (FMS) shows strong growth, with shares up 32.95% YoY and net income up 60%.",
      "url": "https://finnhub.io/api/news?id=83b07a312a7f7754f62829c379b3db180b810a2ae520db47a46e34d9a6e63f97"
    }
  }
]